Progyny Revenue and Competitors

Location

$115.5M

Total Funding

Estimated Revenue & Valuation

  • Progyny's estimated annual revenue is currently $473.4M per year.(i)
  • Progyny received $10.0M in venture funding in May 2017.
  • Progyny's estimated revenue per employee is $829,019
  • Progyny's total funding is $115.5M.
  • Progyny's current valuation is $3.9B. (January 2022)

Employee Data

  • Progyny has 571 Employees.(i)
  • Progyny grew their employee count by 29% last year.

Progyny's People

NameTitleEmail/Phone
1
Group VP, MarketingReveal Email/Phone
2
VPReveal Email/Phone
3
Group VP for LaborReveal Email/Phone
4
CEOReveal Email/Phone
5
VP, Operations - Member & Provider ServicesReveal Email/Phone
6
VP Account ManagementReveal Email/Phone
7
SVP, Employer Market StrategyReveal Email/Phone
8
SVP Business DevelopmentReveal Email/Phone
9
VP Employer PartnershipsReveal Email/Phone
10
VP, National AccountsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$120M6758%$315M$1.8B
#2
$75.7M25531%N/AN/A
#3
$13.5M9315%N/AN/A
Add Company

What Is Progyny?

Progyny is the leading fertility benefits company that combines service, science, technology and data to provide fertility solutions for self-insured employers. Progyny's approach offers members a comprehensive value based treatment plan that is based on the latest medical science and technology. The benefit plans are designed to improve outcomes, shorten time to pregnancy and reduce total fertility-related costs. Progyny supports all fertility solutions to include IVF, IUI, embryo banking, egg freezing, adoption and surrogacy.

keywords:Biotechnology,Hardware,Healthcare,Healthcare Providers,Pharmaceuticals

$115.5M

Total Funding

571

Number of Employees

$473.4M

Revenue (est)

29%

Employee Growth %

$3.9B

Valuation

N/A

Accelerator

Progyny News

2022-04-20 - Progyny (PGNY) to Release Quarterly Earnings on Thursday

Analysts expect Progyny to post earnings of $0.02 per share for the quarter. Progyny has set its Q1 2022 guidance at $-0.020-$-0.010 EPS and its...

2022-04-20 - Progyny, Inc. to Present at the BofA Securities 2022 Healthcare Conference - Benzinga

Progyny, Inc. to Present at the BofA Securities 2022 Healthcare Conference. by Globe Newswire. April 28, 2022 5:00 PM | 1 min read.

2022-04-13 - Progyny and RESOLVE to Launch National Infertility ...

NEW YORK, April 19, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility...

2021-10-26 - Progyny Celebrates National Adoption Awareness Month

26 Oct Blog, Surrogacy/Adoption, Let's Talk Fertility, Emotional Support + Awareness Progyny Celebrates National Adoption Awareness Month Posted on October 26, 2021October 26, 2021by Shannon Zuber October 26 At Progyny, we believe everyone who wants to have a child should be able to do so a ...

2021-07-22 - Progyny Webinar: Journey to Fatherhood: Same-sex Couples + Single Fathers by Choice

21 Jul Blog, Let's Talk Fertility Progyny Webinar: Journey to Fatherhood: Same-sex Couples + Single Fathers by Choice Posted on July 21, 2021July 21, 2021by Elizabeth Foot July 21 Join us for the the third and final installment in Progyny's three-part Journey to Fatherhood webinar series di ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$192.7M57135%N/A
#2
$94.4M57230%$1.3M
#3
$100.3M57336%N/A
#4
$100.3M573N/AN/A
#5
$107.4M57348%N/A

Progyny Funding

DateAmountRoundLead InvestorsReference
2016-06-30$15.0MUndisclosedKleiner Perkins Caufield and ByersArticle
2017-05-03$10.0MBKleiner Perkins Caufield and ByersArticle